Eighth Edition - R.3 - Human Fertilisation & Embryology Authority

Index
likely, information provision on 4.2e
of PGD see preimplantation genetic diagnosis (PGD)
ovarian hyperstimulation syndrome (OHSS),
information provision about 4.2g
ovarian tissue, storage 17A, 17.10
overseas countries, travel to,
for surrogacy arrangement 14.3
overseas donors
compensation for loss of earnings 13.5
legal parenthood issues 6.1
overseas healthcare scientists 2.16
P
packaging of gametes/embryos
materials for, procedures to detail specifications T31(26)
for storage T105(15), 17.4b
for transport/transfer T105(15), 15C, 15.14–15.15
container for
T106(15)
documented procedures 15.15a
parent, legal see legal parenthood
parental consent, to disclosure of
identifying information
5F, 30C
parental responsibility 6.2
parental rights, surrogacy arrangements 14.1
parenting, supportive
8A
definition 8.11
welfare of child assessment 8.11
parents
information available for on child’s donor 20.13, 20.14
second
information before consent T60(6), T61(3), T61(6), T62(6)
withdrawal of consent
to be legal parent T64(6), T65(6), 6J, 6.14
partner of patient
civil, legal parenthood 6B, 6.6–6.7
disclosure of identifying information
5F, 30C
genetic testing, ICSI 21.2
information provision before consent
4A
new
of married woman, legal parenthood 6.5
welfare of child risk assessment 8.6b
notification of withdrawal of consent
for legal parenthood T64(6), T65(6), 6J, 6.14
welfare of child risk assessment 8.3, 8.9
see also female partners, as legal parent;
male partners
patients
identification, in witnessing 18.17–18.24
identity confirmation see witnessing
information about, disclosure under statute 30A, 30.12
information for see information provision
(by centre)
information provided by see information
provision by patients
medical records see medical records, patients’
needs/preferences, considered in treatment provision 29.6
registration, for exported/imported gametes
16A
selection, policy on, information on 4.2a
see also users
payments for donors T69(13), 13.A, 13.1–13.9
as criminal offence
13A
donor compensation see compensation
or loss of earnings, donors
expense reimbursement see expenses
of donors
flat rate not allowed 13A, 13.1
person responsible to ensure no payments 13.7
prohibition
T69(13)
recording/log 13.10
for use of gametes/embryos for research
not allowed
R24(22)
perinatal mortality, risk/rate 7.6b
person responsible (PR) 1A, 1.1–1.5
appointment/appointing
1A
controlling access to records T45(30), 31.7
for genetic testing service 2.20, 2.24
HFEA approval requirement
1A
informing about conscientious objection 29.12
licence holder as 1.1
new, designation of 1.1
notification of withdrawal of consent
for legal parenthood T64(6), T65(6), 6J, 6.14
number of treatment cycles at centre 25.10
qualifications T8(1), 1.3–1.4
quality policy signed/issued by 23.8a
recording of conscientious objection 29.15
requirements, transport centres 24.4
research vs treatment licences, separation 22.1
responsibilities T9(1), 1B, 1.5
under agreements between licensed centres 24.6
for altering of licensed premises
T18(25)
on conscientious objection by staff 29.13, 29.14, 29.15
to ensure no payments/benefits for donors 13.7
importing/exporting of gametes/embryos 16A, 16B, 16C
to report adverse events/reactions
to the Authority
T120(27)
on termination of activities, transfer
of gametes/embryos and information
T10(1)
specialist advice, requirement to seek 1.4
substitute, nomination
T7(1)
supervision of activities on licensed premises T1(25)
unable to carry out duties
T7(1)
unavailability 1.2
personnel see staff
Persons Responsible Entry Programme
(PREP) assessment
T8(1), 1A
polar body biopsy
T88(9), T90(9)
restrictions on use
T88(10)
post-thaw quality, documents indicating,
in cryopreserved gametes 15.19
Human Fertilisation and Embryology Authority
Index
Version 3.0